RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-167546 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Rheumatoid Arthritis Diagnosis Tests Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET

7.1 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Abbott Diagnostics

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Antibodies Incorporated

16.3 Beckman Coulter, Inc.

16.4 Euro Diagnostica AB

16.5 Thermo Fisher Scientific Inc.

16.6 Qiagen NV

16.7 F. Hoffmann-La Roche Ltd.

16.8 Siemens Healthcare GmbH

16.9 Bio Rad Laboratories

16.10 Aviva Systems Biology

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Diagnostic Test Type
Serology Tests
 o Erythrocyte Sedimentation Rate (ESR) through lens Loupes
 o Rheumatoid Factor (RF)
 o Anti–cyclic Citrullinated Peptide (anti–CCP)
 o Antinuclear Antibody (ANA)
 o Uric Acid
 o Other Tests
Monitoring RA Treatment Efficiency Tests
 o Salicylate Level Count
 o Muscle Enzyme Tests
 o Creatinine Test

By End User
Hospitals
Diagnostic Laboratories
 o Private Laboratories
 o Public Laboratories
Ambulatory Surgical Centers

Companies

Abbott Diagnostics
Antibodies Incorporated
Beckman Coulter, Inc.
Euro Diagnostica AB
Thermo Fisher Scientific Inc.
Qiagen NV
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Bio Rad Laboratories
Aviva Systems Biology

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.